Piramal Pharma Ltd Sees Surge in Call Options with 18,504 Contracts Traded Today

Piramal Pharma Ltd has emerged as one of the most active stocks today in the Pharmaceuticals & Biotechnology sector, reflecting significant trading activity in its call options. The stock, which has a market capitalization of Rs 25,661 crore, saw notable movements with two key call options set to expire on September 30, 2025.
The call option with a strike price of Rs 195 witnessed the trading of 7,209 contracts, generating a turnover of Rs 1,459.82 lakh, while the option priced at Rs 200 attracted 11,295 contracts, resulting in a turnover of Rs 1,826.97 lakh. The underlying value of Piramal Pharma stands at Rs 200.99, indicating a robust interest in these options.

In terms of performance metrics, Piramal Pharma outperformed its sector by 6.27%, achieving an intraday high of Rs 201.31, which represents a 7.82% increase. The stock's weighted average price suggests that more volume was traded closer to its low price, and it remains above its 5-day, 20-day, and 50-day moving averages, although it is below the 100-day and 200-day moving averages.

Despite a slight decline in delivery volume, which fell by 3.1% against the 5-day average, the stock maintains sufficient liquidity for trades of Rs 0.84 crore, indicating a stable trading environment. Overall, Piramal Pharma's activity today highlights its dynamic position within the market.